The transformative potential of digital therapeutics in pediatrics

Vina Mohabir, Chitra Lalloo, Andrew M. Briggs, Christopher Eccleston, Courtney Hess, Quynh Pham, Helen Slater, Pedro Velmovitsky, Jennifer N. Stinson

Research output: Contribution to journalReview articlepeer-review

Abstract

ABSTRACT: Digital therapeutics (DTx) are applied healthcare technologies designed to prevent, manage, or treat health conditions. In pediatric pain, DTx can enhance access to evidence-based, effective pain assessment and management. This article explores technologies such as artificial intelligence (AI), extended reality (XR), mobile health (mHealth), and sensors (eg, smartwatches). Equitable DTx deployment can address geographic disparities by enabling on-demand pain care, necessitating an intelligent learning DTx-enabled health system. Ensuring safety will require comprehensive regulatory frameworks at national and international levels. Achieving this transformation requires robust regulatory frameworks, workforce training, and equitable codesign to ensure accessible, evidence-based care for all pediatric populations.

Original languageEnglish
Pages (from-to)S121-S130
Number of pages10
JournalPain
Volume166
Issue number11 S1
Early online date1 Nov 2025
DOIs
Publication statusPublished - 1 Nov 2025

Acknowledgements

A special thanks to the SickKids Pain Centre Patient and Family Advisory committee for their insight into their vision on the future of digital therapeutics for pediatric pain.

Keywords

  • Digital therapeutics
  • Pediatric pain
  • Pediatric pain assessment
  • Pediatric pain management

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology
  • Anesthesiology and Pain Medicine

Fingerprint

Dive into the research topics of 'The transformative potential of digital therapeutics in pediatrics'. Together they form a unique fingerprint.

Cite this